Send me more jobs like this

Executive/Sr. Executive - Instrumentation

Keywords / Skills : Automation, Instrumentation Engineer, Allen Bradley, Siemens, Omron PLCs

2 - 4 years
Posted: 2018-10-17

Job Description

• Candidate should be preferably from Pharma API/Chemical Manufacturing Industry – Instrumentation maintenance background

• Should be capable to handle Instrumentation/Automation related break downs and be able to rectify with minimum downtime

• Should have hands on experience in handling all the filed Instruments like pressure, Temperature, Level, Flow, Weighing Transmitters, online pH/Do2/Conductivity/TOC/UV analyzers, Control Valves, VFDs and data Loggers

• Experience in trouble shooting of Allen Bradely, Siemens and Omron PLCs

• Experience in Handling PM and Calibration documents, SAP for spares maintenance

• Candidate should be willing to work in shifts

About Company

Biocon is Asia’s premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world.

We have evolved from manufacturing pharmaceuticals like statins and immunosuppresants, to discovering, developing and producing biologics in chronic therapies such as diabetes, oncology and immunology for global markets. This has translated into a diversified and differentiated pipeline of fermentation-derived complex generics, biosimilars that include insulins and monoclonal antibodies, and novel biologics.

Biocon is among the few companies globally to have received approvals for its biosimilars from developed countries like the U.S., EU, Australia and Japan. Our credibility as a serious player in the biosimilars sector was first established with the Japanese approval for Insulin Glargine. The credibility was enhanced when Biocon, along with partner Mylan, became the first globally to get biosimilar Trastuzumab and Pegfilgrastim approved in the U.S. in 2017 and 2018, respectively. We were also among the first few to receive Insulin Glargine approval in Europe and Australia for Insulin Glargine, both in partnership with Mylan. We have also established our presence in key emerging markets through safe, effective and high quality biosimilars including recombinant human insulin.

A combination of specialized talent, state-of-the-art research and manufacturing infrastructure and a culture of deep science and regulatory compliance have differentiated us in the marketplace and given us a distinct competitive edge. It has also led to Biocon being recognized as a credible global biopharmaceuticals player.
Similar Jobs
View All Similar Jobs
Walkin for you